Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

960
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
960
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

570
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
570
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

852
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
852
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

760
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
760

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

To disclose or not to disclose? Mental health service users' and practitioners' views of practitioners' own self-disclosure of mental health difficulties: A mixed-methods study.

PLOS mental health·2026
Same author

A Case Series Examining Clinic, Laboratory, and Physical Function After Administration of Nusinersen in Adults With Spinal Muscular Atrophy, a Single-Center Study.

Journal of clinical neuromuscular disease·2024
Same author

Exploring opportunities beyond clinical practice: The need for PA educators.

JAAPA : official journal of the American Academy of Physician Assistants·2024
Same author

When and How to Utilize Pudendal Nerve Blocks for Treatment of Pudendal Neuralgia.

Clinical obstetrics and gynecology·2022
Same author

A practical approach to selecting a colorectal cancer screening test.

JAAPA : official journal of the American Academy of Physician Assistants·2021
Same author

Preparedness for Clinical Practice and the Development of Professional Competencies.

The journal of physician assistant education : the official journal of the Physician Assistant Education Association·2019

Video Experimental Relacionado

Updated: Feb 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.7K

Actualización clínica sobre la colitis ulcerosa para atención primaria

Sarah Bolander1, Kimberly Carter, Tiffany Cooke

  • 1Sarah Bolander is an assistant professor at Northern Arizona University in Phoenix, AZ. Kimberly Carter is an associate professor and director of clinical education at Midwestern University in Glendale, AZ. Tiffany Cooke is an assistant clinical professor at Northern Arizona University. Nicole Hamilton is an assistant professor at Midwestern University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

JAAPA : official journal of the American Academy of Physician Assistants
|February 24, 2026
PubMed
Resumen

La colitis ulcerosa (CU), una enfermedad inflamatoria intestinal (EII) crónica, requiere un reconocimiento temprano para un manejo eficaz. Los avances en los tratamientos, incluidos los biológicos y las moléculas pequeñas, ofrecen mejores opciones para los pacientes con esta afección.

Palabras clave:
biológicosbiosimilaresgastrointestinalinmunomoduladoresenfermedad inflamatoria intestinalcolitis ulcerosa

Más Videos Relacionados

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

13.0K
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.8K

Videos de Experimentos Relacionados

Last Updated: Feb 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.7K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

13.0K
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.8K

Área de la Ciencia:

  • Gastroenterología
  • Inmunología

Sus antecedentes:

  • La colitis ulcerosa (CU) es una enfermedad inflamatoria intestinal (EII) crónica que causa inflamación en el colon y el recto.
  • Síntomas como diarrea con sangre y dolor abdominal alteran significativamente la calidad de vida.

Objetivo del estudio:

  • Destacar la necesidad crítica del reconocimiento temprano de la colitis ulcerosa.
  • Analizar los avances terapéuticos recientes y la importancia de la selección individualizada del tratamiento.

Principales métodos:

  • Revisión de la literatura actual sobre el manejo de la colitis ulcerosa.
  • Análisis de intervenciones farmacológicas y no farmacológicas novedosas.
  • Énfasis en un enfoque multidisciplinario para la atención del paciente.

Principales resultados:

  • Nuevos agentes biológicos, moléculas pequeñas y biosimilares han ampliado la accesibilidad del tratamiento.
  • La selección del tratamiento se adapta a la gravedad de la enfermedad, la ubicación y las necesidades del paciente.
  • Las terapias adyuvantes y un equipo multidisciplinario mejoran la atención integral.

Conclusiones:

  • Optimizar la terapia es clave para inducir/mantener la remisión, promover la curación de la mucosa y prevenir la progresión de la enfermedad.
  • Un enfoque colaborativo y multidisciplinario es esencial para mejorar los resultados a largo plazo en pacientes con colitis ulcerosa.